follitropin alfa

This page contains recent news articles, when available, and an overview of follitropin alfa but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

EMD Serono, Inc. and Nationally Ranked US Hospital Announce Collaboration in ...  -  ‎Dec 16, 2009‎
EMD Serono is a leader in reproductive health, with Gonal-f® (follitropin alfa for injection), Luveris® (lutropin alfa for injection) and Ovidrel® Prefilled ... PR Newswire (press release)

Merck Serono kundigt Grundlagenforschung und klinischer Forschung bei ...  -  ‎Dec 16, 2009‎
Interferon beta-1a), Unfruchtbarkeit (Gonal-f(R), Follitropin alfa), endokrinen und metabolischen Erkrankungen (Saizen(R) und Serostim(R), Somatropin; ... news aktuell Schweiz (Pressemitteilung)

Video: EMD Serono Holds Topping Off Ceremony to Mark Milestone in the ...  -  ‎Oct 19, 2009‎
EMD Serono is a leader in reproductive health, with Gonal-f(®) (follitropin alfa for injection), Luveris(®) (lutropin alfa for injection) and Ovidre(®) ... Reuters

Follitropin Alfa (Systemic).(Gonal-F drug overview)(Drug overview)  -  Aug 1, 2006
Follitropin alfa (fol-li-TROE-pin AL-fa) is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Lutropin alfa (Systemic).  -  Jul 28, 2005
It is usually given in combination with follitropin alfa. ... Follitropin alfa often requires that another hormone called human chorionic gonadotropin (hCG) ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Follitropin Alfa (Systemic).  -  Feb 1, 2006
Follitropin alfa (fol-li-TROE-pin AL-fa) is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

FOLLITROPIN ALFA (Subcutaneous route) - fol-i-TROE-pin AL-fa.(Drug …  -  May 1, 2007
Follitropin alfa is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. FSH helps to develop eggs in the ovaries. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Assisted Reproduction; Study: Use of r-hFSH follitropin alfa in IVF...  -  Mar 14, 2005
2005 MAR 14 - (NewsRx.com) -- Researchers with Serono Ltd., Feltham, UK, and the UK Gonal-f FbM PMS Group reported study results indicating that use of ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Assisted Reproduction; Study: Use of r-hFSH follitropin alfa in IVF...  -  Mar 17, 2005
2005 MAR 17 - (NewsRx.com) -- Researchers with Serono Ltd., Feltham, UK, and the UK Gonal-f FbM PMS Group reported study results indicating that use of ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones

Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat...  -  Sep 25, 2006
Using the Gonal-f(R) RFF Pen, patients administered a fixed dose of recombinant follitropin alfa for 5 days followed by dose adjustment if necessary until a ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: Study Shows Patient Preference for Gonal-f(R) RFF Pen ...  -  Sep 25, 2006
Inc. two new marketing approvals for Gonal-F(R) (follitropin alfa for injection ... agency has approved a 37.5 IU dose of Gonal-F(R), ... Pay-Per-View - PR Newswire - HighBeam Research

Company Profile Report  -  Mar 29, 2008
Merck Serono Gonal-F (Follitropin Alfa); Merck Serono Gonal-F Pen (Follitropin Alfa Injection); Merck Serono Serophene (Clomiphene Citrate). Progestins ... $50.00 - Revere Reports - Revere

Company Profile Report  -  Mar 1, 2008
Serophene (Clomiphene Citrate); Gonal-F Pen (Follitropin Alfa Injection) ... Gonal-F (Follitropin Alfa). Weight Management. Cachexia. Growth Hormones ... $50.00 - Revere Reports - Revere

Competition is needed in the follicle stimulating hormone (FSH) market  -  Nov 14, 2005
...global market of recombinant human FSH (rhFSH) in 2004 was shared between Serono (63 % for follitropin alfa) and Organon (37 % for follitropin beta). ... i-newswire.com

Brooke Shields Lends Her Support to Encourage Women to Take Action …  -  Nov 3, 2005
The Company has seven recombinant products, Rebif(R) (interferon beta-1a), Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa), ... $4.95 - PR Newswire - ECNext

TEXT-EU agency says expert committee backs new drugs  -  Apr 27, 2007
...*Pergoveris (follitropin alfa and lutropin alfa), from Serono Europe Ltd, intended for the stimulation of follicular development in women with severe ... Reuters

Merck's Fertility Treatment Pergoveris Approved in the European Union  -  Jun 29, 2007
Pergoveris is the first biotechnology product based on the combination of recombinant human FSH (r-hFSH or follitropin alfa 150IU) and recombinant human LH ... FDA news - FDA news (subscription)

Meeting Highlights From The Committee For Medicinal Products For …  -  Apr 23, 2007
Pergoveris (follitropin alfa and lutropin alfa), from Serono Europe Ltd, intended for the stimulation of follicular development in women with severe ... Medical News Today - Medical News Today (press release)

News In Brief  -  Jun 5, 2005
...other main products in the quarter, including Rebif (interferon beta-1a) for multiple sclerosis and Gonal-F (follitropin alfa) infertility treatment. PM ... Nature.com

Phase III Trial Of Oral Cladribine, A Novel Investigational Therapy...  -  May 5, 2006
The Company has seven biotechnology products in the US, Rebif(R) (interferon beta-1a), Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin ... Medical News Today - Medical News Today (press release)

ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc.  -  Sep 4, 2007
In addition, EMD Serono has agreed to provide certain quantities of two of its products, Gonal-f(R) RFF Pen (follitropin alfa injection) and Ovidrel(R) ... Genetic Engineering News - Genetic Engineering News (press release)

Serono Announces Formal Conclusion of Serostim Settlement.  -  Dec 15, 2005
The company's US products are Rebif(R) (interferon beta-1a), Novantrone(R) (mitoxantrone for injection concentrate), Gonal-f(R) (follitropin alfa for ... Free with registration - PR Newswire - AccessMyLibrary.com

EC approves Merck KGaA's Pergoveris.(European Commission)(Brief …  -  Jul 9, 2007
The agent is the first biotechnology product based on the combination of recombinant human FSH (r-hFSH or follitropin alfa 150IU) and recombinant human LH ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Press Release: Merck Serono Submits Application for GONAL-f(R) in …  -  Oct 24, 2008
Labor and Welfare for a new indication of GONAL-f(R) / GONALEF(R) (follitropin alfa for injection) for ovulation induction in infertile women. ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Merck Serono's Pergoveris approved in EU.(Global News Network)  -  Aug 1, 2007
Pergoveris is the first biotechnology product based on the combination of recombinant human FSH (r-hFSH or follitropin alfa 150IU) and recombinant human LH ... Free with registration - Biopharm International - AccessMyLibrary.com

Serono's Gonal-f Approved in Japan for the Treatment of Male …  -  Jan 24, 2006
Labour and Welfare (MHLW) has approved Gonal-f® 75 IU and Gonal-f® 150 IU (follitropin alfa recombinant) subcutaneous injection for co-administration ... DG News

Press Release: First Regional University for Women in Asia Hosts …  -  Aug 28, 2008
PR Newswire Europe; July 16, 2009 ; 700+ words ... ... follitropin alfa for injection) to infertile women suffering from irregular or no ovulation ... Pay-Per-View - PR Newswire Europe - HighBeam Research

EU approves recombinant fertility drug duo  -  Jul 3, 2007
...called Pergoveris, is unique in that it is the first to combine recombinant human follicle stimulating hormone (FSH) (r-hFSH or follitropin alfa 150IU) ... In-PharmaTechnologist.com

Competition is needed in the follicle stimulating hormone (FSH) market  -  Nov 16, 2005
...global market of recombinant human FSH (rhFSH) in 2004 was shared between Serono (63 % for follitropin alfa) and Organon (37 % for follitropin beta). ... prleap.com

Press Release: Get Answers to the Burning Questions About Women's …  -  Aug 28, 2008
PR Newswire Europe; July 16, 2009 ; 700+ words ... ... follitropin alfa for injection) to infertile women suffering from irregular or no ovulation ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Serono's Gonal-f approved in Japan.(Japan's Ministry of Health and …  -  Jan 30, 2006
Labor and Welfare has approved its Gonal-f 75 IU and Gonal-f 150 IU (follitropin alfa recombinant) subcutaneous injection for co-administration with ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Pharmacy Update: A helping hand.  -  Aug 11, 2007
FSH alone (urofollitropin, follitropin alfa and follitropin beta). * LH alone (lutropin alfa). * Chorionic gonadotrophin (choriogonadotropin alfa and human ... $9.94 - Chemist & Druggist - Alacra Store

Federal Register 2006 - 71 FR 34136 Determination of Regulatory …  -  Jun 13, 2006
LUVERIS, concomitantly administered with follitropin alfa for injection, is indicated for stimulation of follicular development in infertile ... Pay-Per-View - Federal Register 2006 - Loislaw

Serono Announces Significant Advances in Identifying Most Viable …  -  Oct 17, 2005
...including the newly approved Gonal-f(R) RFF Pen (follitropin alfa injection). For more information, please contact Fertility LifeLines(TM), ... Free with registration - PR Newswire - AccessMyLibrary.com

Merck Serono picks Huntsworth for infertility work  -  Jan 26, 2007
The agency will produce a new campaign for Gonal-f (follitropin alfa) combining advertising and promotional materials. The drug is prescribed to supplement ... Pharmafocus

SERONO'S GONAL-F APPROVED IN JAPAN FOR HYPOGONADISM.  -  Mar 1, 2006
75 IU and Gonal-f(R) 150 IU (follitropin alfa recombinant) subcutaneous injection for co-administration with Profasi(R) 5000 IU (chorionic gonadotropin) ... $4.95 - Worldwide Biotech - ECNext

James Greenwood Assumes BIO Presidency as Industry Has Banner …  -  Jan 5, 2005
March 2003) Gonal-f(R) Serono Inc. FDA approved prefilled device 5/25/04 RFF Pen (drug is used for infertility) (follitropin alfa injection) Norditropin ... $4.95 - PR Newswire - ECNext

Press Release: Merck Serono's Fertility Treatment Pergoveris(TM) …  -  Jun 29, 2007
Pergoveris(TM) is the first biotechnology product based on the combination of recombinant human FSH (r-hFSH or follitropin alfa 150IU) and recombinant human ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Article: Serono ends sale talks.(News) - The Journal (Newcastle,...  -  Apr 11, 2006
...announced today that the US Food and Drug Administration (FDA) has approved new presentations of Gonal-f(R) (follitropin alfa for injection) including . ... Pay-Per-View - The Journal - HighBeam Research

Assisted Reproduction; Researchers' findings advance assisted …  -  Apr 19, 2005
A recent cost-effectiveness analysis on follitropin alfa compared to urinary FSH-HP, using a Markov model, confirmed [findings of] other previous studies ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Factiva Search  -  Oct 24, 2006
Assisted Reproduction; Study shows patients prefer follitropin alfa injection over vials to treat infertility. 24 October, 2006 Life Science Weekly ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Assisted Reproduction; Researchers' findings advance assisted …  -  Apr 18, 2005
A recent cost-effectiveness analysis on follitropin alfa compared to urinary FSH-HP, using a Markov model, confirmed [findings of] other previous studies ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Collaborations; Serono and Syntonix agree to pursue development of …  -  Oct 16, 2006
Serono has led in the treatment of infertility and currently markets GONAL-f (follitropin alfa), a highly consistent recombinant human follicle-stimulating ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Merck KGaA posts 49% net profit rise for 2006, with revenues up 8.5%.  -  Mar 12, 2007
In 2006, sales from Gonal-f (follitropin alfa, recombinant) decreased 2.5% to $533.0 million and fell 1.2% to $132.0 million in the fourth quarter. ... $9.94 - Pharma Marketletter - Alacra Store

Factiva Search  -  Mar 14, 2005
Assisted Reproduction; Study: Use of r-hFSH follitropin alfa in IVF is safe, effective. 14 March, 2005 OBGYN & Reproduction Week ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Serono's 3rd-qtr 2006 sales rise 8.4% on Rebif.  -  Oct 30, 2006
...however, they noted that sales of Gonal-f (follitropin alfa recombinant) disappointed their expectations, with a 2.2% decline to $122.8 million. ... $9.94 - Pharma Marketletter - Alacra Store

Press Release: Boom in Female Wealth Creation Driven by Business …  -  Jun 10, 2007
PR Newswire Europe; July 16, 2009 ; 700+ words ... ... follitropin alfa for injection) to infertile women suffering from irregular or no ovulation ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Fertility LifeLines(TM) Offers Single Destination for Access to...  -  Aug 10, 2005
...cycle and recombinant versions of three hormones used in the treatment of infertility, including the Gonal-f(R) RFF Pen (follitropin alfa injection). ... $4.95 - PR Newswire - ECNext

Press Release: Serono's Gonal-f(R) Approved in Japan for the Treatment...  -  Jan 24, 2006
75 IU and Gonal-f(R) 150 IU (follitropin alfa recombinant) subcutaneous injection for co-administration with Profasi(R) 5000 IU (chorionic gonadotropin) ... Pay-Per-View - PR Newswire - HighBeam Research

Factiva Search  -  Mar 16, 2005
Serono Ltd. Study: Use of r-hFSH follitropin alfa in IVF is safe, effective. 16 March, 2005 Biotech Week. 2005 MAR 16 - (NewsRx.com) -- Researchers with ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Press Release: Serono and Syntonix to Pursue the Development of a …  -  Sep 18, 2006
Serono is the world leader in the treatment of infertility and currently markets GONAL-f(R) (follitropin alfa), a highly consistent recombinant human ... Pay-Per-View - PR Newswire - HighBeam Research

Assisted Reproduction; Researchers' findings advance assisted …  -  Apr 23, 2005
A recent cost-effectiveness analysis on follitropin alfa compared to urinary FSH-HP, using a Markov model, confirmed [findings of] other previous studies ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Press Release: Serono Welcomes Positive Ratings From Credit Agencies …  -  Jul 13, 2005
...announced today that the US Food and Drug Administration (FDA) has approved new presentations of Gonal-f(R) (follitropin alfa for injection) including . ... Pay-Per-View - PR Newswire - HighBeam Research

Serono and Priority Healthcare Corporation Form Strategic Alliance.  -  Jun 14, 2005
...cycle and recombinant versions of three hormones used in the treatment of infertility, including the Gonal-f(R) RFF Pen (follitropin alfa injection). ... $4.95 - PR Newswire - ECNext

heftige Schmerzen schon seit 10 Tagen  -  Jul 25, 2007
Dann sollte ich gonal-f spritzen = Follitropin Alfa (gentechnologisch gewonnenes rekombinantes FSH), die sehr selten Thrombosen als Nebenwirkungen haben. ... Onmeda

신약 출시 ë”°ë?¼ MR 단계ì ? 확대 계íš?  -  Nov 30, 2007
...�업체제는 암, ��건강, 대사성내분비, �명주기 등 4개 분야를 �고, 불임 치료제 ' 고날 �프'(Gonal-F, follitropin alfa)와 성장호르몬제제� '싸�젠'(Saizen, ... 디지틀보사





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy